Moreover, the treatment of human patient-derived glioblastoma cells with ∆9-THC has been shown to reduce the number of Ki67-labelled cells, through the orphan cannabinoid receptor GPR55 (Kolbe et al., 2021). This evidence concerns the gene MKI67 and glioblastoma.